FemCelz; as previously announced, we are progressing with the development of the FemCelz procedure for the treatment of female sexual dysfunction using stem cells from the patient's own bone marrow. Following the same model as CaverStem™, we anticipate launching this program in Q1 2019.
Market Data 
Markets 
AI
